Metabotropic Glutamate Receptor 4 Key Players – Addex Therapeutics Ltd, Domain Therapeutics SA, and Prexton Therapeutics SA Analysis & Forecast to 2022

Metabotropic Glutamate Receptor 4

Overview

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein encoded by the GRM4 gene. It is a G-protein coupled receptor for glutamate.

Glutamate binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811477-metabotropic-glutamate-receptor-4-gprc1d-or-mglur4-or-grm4-pipeline

Top Companies mentioned

Addex Therapeutics Ltd

Domain Therapeutics SA

Prexton Therapeutics SA

Metabotropic Glutamate Receptor 4 Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Metabotropic Glutamate Receptor 4  - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Metabotropic Glutamate Receptor 4 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1 and 2 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively. Report covers products from therapy areas Central Nervous System which include indications Parkinson's Disease, Anxiety Disorders, Autism, Depression, Drug Addiction, Infantile Spasm (West Syndrome), Multiple Sclerosis, Obsessive-Compulsive Disorder, Psychosis, Status Epilepticus and Substance (Drug) Abuse.

Metabotropic Glutamate Receptor 4 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Metabotropic Glutamate Receptor 4 - Competitive Analysis

Key players are making innovative developments in Metabotropic Glutamate Receptor 4 industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Metabotropic Glutamate Receptor 4.

The pipeline guide reviews pipeline therapeutics for Metabotropic Glutamate Receptor 4 by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Metabotropic Glutamate Receptor 4 therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Metabotropic Glutamate Receptor 4 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Metabotropic Glutamate Receptor 4.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2811477-metabotropic-glutamate-receptor-4-gprc1d-or-mglur4-or-grm4-pipeline

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.